Analysis of current data on the use of topical <scp>mTOR</scp> inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex

Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex—An update

Published:2022-11-05 Issue:3 Volume:37 Page:474-487
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Balestri Riccardo¹^ORCID,Rizzoli Laura¹,Pedrolli Annalisa²,Urru Silvana Anna Maria³,Rech Giulia¹,Neri Iria⁴,Girardelli Carlo R.¹,Magnano Michela¹^ORCID

Affiliation:

1. Division of Dermatology Outpatient Consultation for Rare Diseases Trento Italy

2. Division of Pediatrics Outpatient Consultation for Rare Diseases Trento Italy

3. Hospital Pharmacy Unit, Trento General Hospital, Autonomous Province of Trento Trento Italy

4. Dermatology Unit, IRCSS Policlinico di S. Orsola, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna Bologna Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18693

Reference51 articles.

1. Topical Rapamycin

2. Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin

3. Dramatic Improvement of Facial Angiofibromas in Tuberous Sclerosis With Topical Rapamycin: Optimizing a Treatment Protocol

4. Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibroma

5. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL −1 ) in two patients with tuberous sclerosis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review);International Journal of Molecular Medicine;2024-08-05

2. A Systematic Review of Laser Treatment for Angiofibromas in Tuberous Sclerosis;Dermatologic Surgery;2024-05-13

3. Pathology of hereditary renal cell carcinoma syndromes: Tuberous sclerosis complex (TSC);Seminars in Diagnostic Pathology;2024-01

4. Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology;Journal of the European Academy of Dermatology and Venereology;2023-12-21

5. Analyses bibliographiques « automne 2023 »;Annales de Dermatologie et de Vénéréologie - FMC;2023-09